A citation-based method for searching scientific literature

Francesca Ferrante, Benedetto Daniele Giaimo, Marek Bartkuhn, Tobias Zimmermann, Viola Close, Daniel Mertens, Andrea Nist, Thorsten Stiewe, Johanna Meier-Soelch, Michael Kracht, Steffen Just, Patricia Klöble, Franz Oswald, Tilman Borggrefe. Nucleic Acids Res 2020
Times Cited: 12







List of co-cited articles
78 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A phospho-dependent mechanism involving NCoR and KMT2D controls a permissive chromatin state at Notch target genes.
Franz Oswald, Patrick Rodriguez, Benedetto Daniele Giaimo, Zeus A Antonello, Laura Mira, Gerhard Mittler, Verena N Thiel, Kelly J Collins, Nassif Tabaja, Wiebke Cizelsky,[...]. Nucleic Acids Res 2016
46
33


Leukemia-specific delivery of mutant NOTCH1 targeted therapy.
Giovanni Roti, Jun Qi, Samuel Kitara, Marta Sanchez-Martin, Amy Saur Conway, Anthony C Varca, Angela Su, Lei Wu, Andrew L Kung, Adolfo A Ferrando,[...]. J Exp Med 2018
18
25

FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
Jennifer O'Neil, Jonathan Grim, Peter Strack, Sudhir Rao, Deanne Tibbitts, Christopher Winter, James Hardwick, Markus Welcker, Jules P Meijerink, Rob Pieters,[...]. J Exp Med 2007
504
25

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Andrew P Weng, Adolfo A Ferrando, Woojoong Lee, John P Morris, Lewis B Silverman, Cheryll Sanchez-Irizarry, Stephen C Blacklow, A Thomas Look, Jon C Aster. Science 2004
25

Notch in Leukemia.
Anna C McCarter, Qing Wang, Mark Chiang. Adv Exp Med Biol 2018
17
25



The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways.
Tilman Borggrefe, Matthias Lauth, An Zwijsen, Danny Huylebroeck, Franz Oswald, Benedetto Daniele Giaimo. Biochim Biophys Acta 2016
125
25

Introduction to Molecular Mechanisms in Notch Signal Transduction and Disease Pathogenesis.
Benedetto Daniele Giaimo, Tilman Borggrefe. Adv Exp Med Biol 2018
9
33

Hdac3 is essential for the maintenance of chromatin structure and genome stability.
Srividya Bhaskara, Sarah K Knutson, Guochun Jiang, Mahesh B Chandrasekharan, Andrew J Wilson, Siyuan Zheng, Ashwini Yenamandra, Kimberly Locke, Jia-Ling Yuan, Alyssa R Bonine-Summers,[...]. Cancer Cell 2010
251
25

Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL.
Luca Tottone, Nadezda Zhdanovskaya, Álvaro Carmona Pestaña, Michele Zampieri, Fabrizio Simeoni, Sara Lazzari, Valeria Ruocco, Maria Pelullo, Paola Caiafa, Maria Pia Felli,[...]. Front Oncol 2019
23
25

The Varied Roles of Notch in Cancer.
Jon C Aster, Warren S Pear, Stephen C Blacklow. Annu Rev Pathol 2017
315
25

Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells.
Tessa Knox, Eva Sahakian, Debarati Banik, Melissa Hadley, Erica Palmer, Satish Noonepalle, Jennifer Kim, John Powers, Maria Gracia-Hernandez, Vasco Oliveira,[...]. Sci Rep 2019
82
16

HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants.
Andrew Nguyen, Louisa Ho, Samuel T Workenhe, Lan Chen, Jonathan Samson, Scott R Walsh, Jonathan Pol, Jonathan L Bramson, Yonghong Wan. Cell Rep 2018
11
18

MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas.
Ophélia Maertens, Ryan Kuzmickas, Haley E Manchester, Chloe E Emerson, Alessandra G Gavin, Caroline J Guild, Terence C Wong, Thomas De Raedt, Christian Bowman-Colin, Elodie Hatchi,[...]. Cancer Discov 2019
38
16

HDAC3 Inhibition Upregulates PD-L1 Expression in B-Cell Lymphomas and Augments the Efficacy of Anti-PD-L1 Therapy.
Siyu Deng, Qianwen Hu, Heng Zhang, Fang Yang, Cheng Peng, Chuanxin Huang. Mol Cancer Ther 2019
43
16

HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy.
Michael F Emmons, Fernanda Faião-Flores, Ritin Sharma, Ram Thapa, Jane L Messina, Jurgen C Becker, Dirk Schadendorf, Edward Seto, Vernon K Sondak, John M Koomen,[...]. Cancer Res 2019
35
16

HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer.
Yue Xue, Wenwen Lian, Jiaqi Zhi, Wenjuan Yang, Qianjin Li, Xingyi Guo, Jiahao Gao, Hao Qu, Weiqiang Lin, Zhongqi Li,[...]. Br J Cancer 2019
17
16

Direct inhibition of the NOTCH transcription factor complex.
Raymond E Moellering, Melanie Cornejo, Tina N Davis, Cristina Del Bianco, Jon C Aster, Stephen C Blacklow, Andrew L Kung, D Gary Gilliland, Gregory L Verdine, James E Bradner. Nature 2009
565
16

Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia.
Pedro J Real, Valeria Tosello, Teresa Palomero, Mireia Castillo, Eva Hernando, Elisa de Stanchina, Maria Luisa Sulis, Kelly Barnes, Catherine Sawai, Irene Homminga,[...]. Nat Med 2009
326
16

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
C Papayannidis, D J DeAngelo, W Stock, B Huang, M N Shaik, R Cesari, X Zheng, J M Reynolds, P A English, M Ozeck,[...]. Blood Cancer J 2015
71
16

Therapeutic antibody targeting of individual Notch receptors.
Yan Wu, Carol Cain-Hom, Lisa Choy, Thijs J Hagenbeek, Gladys P de Leon, Yongmei Chen, David Finkle, Rayna Venook, Xiumin Wu, John Ridgway,[...]. Nature 2010
523
16

Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia.
Natarajan Valliyammai, Nirmala K Nancy, Tenali G Sagar, Thangarajan Rajkumar. J Pediatr Hematol Oncol 2018
16
16

Significance of NOTCH1 mutations détections in T-acute lymphoblastic leukemia patients.
Salah Aref, Mohammed El Agdar, Osama Salama, Tarek Abouzeid Zeid, Mohamed Sabry. Cancer Biomark 2020
8
25

Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Wei Guan, Yu Jing, Liping Dou, Maoquan Wang, Yang Xiao, Li Yu. Leuk Lymphoma 2020
13
16

A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.
Daniel Herranz, Alberto Ambesi-Impiombato, Teresa Palomero, Stephanie A Schnell, Laura Belver, Agnieszka A Wendorff, Luyao Xu, Mireia Castillo-Martin, David Llobet-Navás, Carlos Cordon-Cardo,[...]. Nat Med 2014
262
16

Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia.
Jolien De Bie, Sofie Demeyer, Llucia Alberti-Servera, Ellen Geerdens, Heidi Segers, Michaël Broux, Kim De Keersmaecker, Lucienne Michaux, Peter Vandenberghe, Thierry Voet,[...]. Leukemia 2018
45
16

Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition.
Roger A Habets, Charles E de Bock, Lutgarde Serneels, Inge Lodewijckx, Delphine Verbeke, David Nittner, Rajeshwar Narlawar, Sofie Demeyer, James Dooley, Adrian Liston,[...]. Sci Transl Med 2019
50
16

Notch signaling as a therapeutic target for acute lymphoblastic leukemia.
Diana Bellavia, Rocco Palermo, Maria Pia Felli, Isabella Screpanti, Saula Checquolo. Expert Opin Ther Targets 2018
27
16

The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
Marta Sanchez-Martin, Adolfo Ferrando. Blood 2017
119
16

TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.
L W Ellisen, J Bird, D C West, A L Soreng, T C Reynolds, S D Smith, J Sklar. Cell 1991
16

Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.
V Agnusdei, S Minuzzo, C Frasson, A Grassi, F Axelrod, S Satyal, A Gurney, T Hoey, E Seganfreddo, G Basso,[...]. Leukemia 2014
83
16

Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.
M Waibel, S J Vervoort, I Y Kong, S Heinzel, K M Ramsbottom, B P Martin, E D Hawkins, R W Johnstone. Leukemia 2018
17
16

Notch functions in developmental and tumour angiogenesis by diverse mechanisms.
Thaned Kangsamaksin, Ian W Tattersall, Jan Kitajewski. Biochem Soc Trans 2014
27
16


Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia.
Panagiotis Ntziachristos, Aristotelis Tsirigos, Pieter Van Vlierberghe, Jelena Nedjic, Thomas Trimarchi, Maria Sol Flaherty, Dolors Ferres-Marco, Vanina da Ros, Zuojian Tang, Jasmin Siegle,[...]. Nat Med 2012
346
16

The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB.
Elisabeth Ziesché, Daniela Kettner-Buhrow, Axel Weber, Tobias Wittwer, Liane Jurida, Johanna Soelch, Helmut Müller, Doris Newel, Petra Kronich, Heike Schneider,[...]. Nucleic Acids Res 2013
80
16

PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes.
Zhonghua Gao, Jin Zhang, Roberto Bonasio, Francesco Strino, Ayana Sawai, Fabio Parisi, Yuval Kluger, Danny Reinberg. Mol Cell 2012
540
16

Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation.
V N Thiel, B D Giaimo, P Schwarz, K Soller, V Vas, M Bartkuhn, T J Blätte, K Döhner, L Bullinger, T Borggrefe,[...]. Leukemia 2017
11
18

Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages.
Xuefen Chen, Iros Barozzi, Alberto Termanini, Elena Prosperini, Antonio Recchiuti, Jesmond Dalli, Flore Mietton, Gianluca Matteoli, Scott Hiebert, Gioacchino Natoli. Proc Natl Acad Sci U S A 2012
225
16

Transcription Factor RBPJ as a Molecular Switch in Regulating the Notch Response.
Benedetto Daniele Giaimo, Ellen K Gagliani, Rhett A Kovall, Tilman Borggrefe. Adv Exp Med Biol 2021
10
20

Structural and Functional Studies of the RBPJ-SHARP Complex Reveal a Conserved Corepressor Binding Site.
Zhenyu Yuan, Bradley D VanderWielen, Benedetto Daniele Giaimo, Leiling Pan, Courtney E Collins, Aleksandra Turkiewicz, Kerstin Hein, Franz Oswald, Tilman Borggrefe, Rhett A Kovall. Cell Rep 2019
22
16

SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway.
Franz Oswald, Ulrike Kostezka, Kathy Astrahantseff, Soizic Bourteele, Karin Dillinger, Ulrich Zechner, Leopold Ludwig, Monika Wilda, Horst Hameister, Walter Knöchel,[...]. EMBO J 2002
208
16


Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.
Ryan D Morin, Maria Mendez-Lago, Andrew J Mungall, Rodrigo Goya, Karen L Mungall, Richard D Corbett, Nathalie A Johnson, Tesa M Severson, Readman Chiu, Matthew Field,[...]. Nature 2011
16

Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1.
Ho-Geun Yoon, Doug W Chan, Zhi-Qing Huang, Jiwen Li, Joseph D Fondell, Jun Qin, Jiemin Wong. EMBO J 2003
341
16

Whole exome sequencing of adenoid cystic carcinoma.
Philip J Stephens, Helen R Davies, Yoshitsugu Mitani, Peter Van Loo, Adam Shlien, Patrick S Tarpey, Elli Papaemmanuil, Angela Cheverton, Graham R Bignell, Adam P Butler,[...]. J Clin Invest 2013
175
16

Decoding the PTM-switchboard of Notch.
Daniel Antfolk, Christian Antila, Kati Kemppainen, Sebastian K-J Landor, Cecilia Sahlgren. Biochim Biophys Acta Mol Cell Res 2019
12
16

Site-specific methylation of Notch1 controls the amplitude and duration of the Notch1 response.
Kerstin Hein, Gerhard Mittler, Wiebke Cizelsky, Michael Kühl, Francesca Ferrante, Robert Liefke, Ina M Berger, Steffen Just, J Eric Sträng, Hans A Kestler,[...]. Sci Signal 2015
43
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.